EN

EN

CN

Español

The Urgent Need to Address the Threat of High Prevalence (≥5%) of Malaria Pfhrp2/3 Gene Deletions 2023-04-25
‘Tripledemic:’ FLU, COVID-19 and RSV. 2023-04-07
Any New Way to Track Omicron Besides the Sequencing? 2021-12-15
Fapon Biotech Races to Introduce Omicron Neutralizing Antibodies Titer Testing Solution 2021-12-09
Fapon Biotech COVID-19 Testing Raw Materials Experimentally Proved to Be Effective on Omicron Variant Detection 2021-12-02
Fapon Biotech’s Splendid Appearance on MEDICA 2021 2021-11-18
Fapon Biotech's Full Acquisition of Sequlite, Expands Its Strategic Presence in High-Throughput NGS 2021-10-29
The Pressing Need for Early Detection of Mucormycosis during COVID-19 2021-06-21
One-Stop Solution for COVID-19 RT-PCR Test Solution 2021-06-07
Fapon Biotech Brings Its Blockbuster Moments at CACLP Expo with COVID-19 Products and Brand Refresh 2021-03-29
Multinational Consulates Visited Fapon Biotech to Exchange COVID-19 Anti-Epandemic Experience 2021-03-24
Newly Released Latex-Enhanced Immunoturbidimetric Raw Materials Adds to COVID-19 NAb Test Solution 2021-03-23
Fapon Biotech Introduces POCT Solution for COVID-19 E484K Mutation Testing 2021-02-19
Effective in Detection, Fapon Biotech Antibodies to COVID-19 Mainstream Variants, Test Kit Verification Service Available 2021-01-20
Fapon Biotech First in World to Introduce COVID-19 Antibodies for Antigen Lateral Flow Testing in Differentiating Variant B.1.1.7 and Wild-Type Virus 2021-01-17
Fapon 19th Anniversary: New Mission, Vision & Core Values Announced 2020-08-12
Fapon COVID-19 Global Donation, 1 Million PCR Diagnostic Products Free of Use 2020-03-09
Fapon at Medlab Middle East, Actions to Coronavirus Outbreak and New IVD Products Roll Out 2020-02-04
Fapon Offers 1 Million Free COVID-19 PCR Test Components to IVD Partners 2020-01-23
Fapon Annual Dinner 2020 Themed up "Value Co-Creation, Effective Implementation" 2020-01-15
Fapon Presents COVID-19 Diagnostic Power at Medical Fair India 2020-03-05

Fapon Biotech Inc.

Fapon Biotech Inc., founded in 2001, adheres to the mission of “Empowering Timely, Accurate and Affordable Diagnosis for All”, while focusing on the future needs and trends of biotechnology development, and committed to providing global diagnostic companies with high-performance IVD reagent raw materials, such as antigens, antibodies, and enzymes, as well as reagent solutions and innovative open instrument platforms. Our products and services are highly integrated, promoting synergic resources and shared-values to the industry, making the developments of diagnostic technologies benefiting more people, advancing the cause of human health.

Learn More

Co-creator of Diagnostic Ecosystem

22

Over 22 years of industry experience

100000

Over 100000m² industry base

1400

Over 1400 products

2500

Over 2500 global business partners

Mission

Empowering Timely, Accurate and Affordable Diagnosis for All.

Values

—

Foresee and Prepare for What Future Demands

The biotechnology industry is changing and iterating rapidly. To create a bright future, we must gain insights into changes, product long-term value propositions of the society and users, embrace the sense of crisis awareness, prepare and respond to changes proactively.

Give Customers the First Priority

Users refer to our customers and the patients and medical practitioners they serve. Our products, solutions, and services must meet the needs of users.

Think with A Collaborative Mind

Our organization is managed to provide vital prerequisites for achieving team goals and objectives. We transform personal wisdom into team wisdom, dare to take responsibilities, make contributions, and get inspiration via teamwork.

Act Nimbly and Efficiently

We believe high efficiency is the result of agility. We are sensitive to markets and opportunities, promote efficient trials and iteration. We work based on the importance and urgency of tasks, dare to try and pursue innovation, aim to deliver the best results within the project lead time.

Work Hard and Actively

Have a positive attitude in challenges and make relentless efforts. We defined goals, maintain a sense of responsibility，devote more time and always go the extra miles for achievements beyond standards.

  • Mission

  • Values

One-Stop Solutions

Experienced, multi-disciplinary R&D and production teams, launch platform-based one-stop solutions in an innovative way to help IVD companies enter various market subdivisions.

Featured Product

CLIA One-Stop Solution

Features

Innovative Design
Incubation, washing and detection all-in-one
Small size ≤38 kg, ideal for different settings
50+ patented technologies, 100% self-developed

User Friendly
Color touchscreen interface, simple and convenient to use
All consumable loading is performed upon user’s request in the control panel

Flexible and High-Quality
Batch/random/STAT mode available
Same reagents and consumables used across the entire Shine series analyzers
Production in accordance with industry standards and regulations

Featured Product

Immunoturbidimetric Reagent Development Solution

Features

OEM service
Customized development for various parameter portfolio
· Jointly development of new projects
· Strategic cooperation in target markets


Service Features
Applicable to use in an extensive range of technological platforms
· Semi/Automatic Biochemistry Analyzers
· Specific Protein Analyzer
· Dry Chemistry
· POCT
Flexible multi-parameter customizable to achieve single/multi-point calibrations
High reaction rate reaching 2.5 to 10min per test
Techniques to scale up for mass production

IVD Reagent Raw Materials

Provide High-Quality Raw Materials Upon The Utilization of Various Bioengineering Technologies

Global Market

Co-creator of Diagnostic Ecosystem

More than 2500 Customers Worldwide

01

Asia

20 Geographic Areas

02

Europe

23 Geographic Areas

03

South America

5 Geographic Areas

04

North America

4 Geographic Areas

05

Africa

4 Geographic Areas

06

Oceania

2 Geographic Areas

Explore Our Global Network

News

  • Company News

  • Marketing Activities

2023-12-01

Fapon’s HIV-P24: Enabling Precise and Early HIV Detection

As a result of global efforts to combat the AIDS epidemic, significant progress has been achieved worldwide. According to UNAIDS, while 39 million people still live with HIV globally, the number of new infections has declined by 38% to 1.3 million in 2022 compared to 2010. Despite these improvements, the battle against HIV persists, as only 86% of newly infected individuals are aware of their HIV status, and approximately 630,000 people worldwide have died from AIDS-related illnesses. The significance of prevention, diagnosis, and treatment in the ongoing fight remains paramount.

2023-12-01

Fapon’s HIV-P24: Enabling Precise and Early HIV Detection

As a result of global efforts to combat the AIDS epidemic, significant progress has been achieved worldwide. According to UNAIDS, while 39 million people still live with HIV globally, the number of new infections has declined by 38% to 1.3 million in 2022 compared to 2010. Despite these improvements, the battle against HIV persists, as only 86% of newly infected individuals are aware of their HIV status, and approximately 630,000 people worldwide have died from AIDS-related illnesses. The significance of prevention, diagnosis, and treatment in the ongoing fight remains paramount.

2023-12-01

Fapon’s HIV-P24: Enabling Precise and Early HIV Detection

As a result of global efforts to combat the AIDS epidemic, significant progress has been achieved worldwide. According to UNAIDS, while 39 million people still live with HIV globally, the number of new infections has declined by 38% to 1.3 million in 2022 compared to 2010. Despite these improvements, the battle against HIV persists, as only 86% of newly infected individuals are aware of their HIV status, and approximately 630,000 people worldwide have died from AIDS-related illnesses. The significance of prevention, diagnosis, and treatment in the ongoing fight remains paramount.

2023-12-01

Fapon’s HIV-P24: Enabling Precise and Early HIV Detection

As a result of global efforts to combat the AIDS epidemic, significant progress has been achieved worldwide. According to UNAIDS, while 39 million people still live with HIV globally, the number of new infections has declined by 38% to 1.3 million in 2022 compared to 2010. Despite these improvements, the battle against HIV persists, as only 86% of newly infected individuals are aware of their HIV status, and approximately 630,000 people worldwide have died from AIDS-related illnesses. The significance of prevention, diagnosis, and treatment in the ongoing fight remains paramount.

2023-12-01

Fapon’s HIV-P24: Enabling Precise and Early HIV Detection

As a result of global efforts to combat the AIDS epidemic, significant progress has been achieved worldwide. According to UNAIDS, while 39 million people still live with HIV globally, the number of new infections has declined by 38% to 1.3 million in 2022 compared to 2010. Despite these improvements, the battle against HIV persists, as only 86% of newly infected individuals are aware of their HIV status, and approximately 630,000 people worldwide have died from AIDS-related illnesses. The significance of prevention, diagnosis, and treatment in the ongoing fight remains paramount.

2023-12-01

Fapon’s HIV-P24: Enabling Precise and Early HIV Detection

As a result of global efforts to combat the AIDS epidemic, significant progress has been achieved worldwide. According to UNAIDS, while 39 million people still live with HIV globally, the number of new infections has declined by 38% to 1.3 million in 2022 compared to 2010. Despite these improvements, the battle against HIV persists, as only 86% of newly infected individuals are aware of their HIV status, and approximately 630,000 people worldwide have died from AIDS-related illnesses. The significance of prevention, diagnosis, and treatment in the ongoing fight remains paramount.

2023-12-01

Fapon's HIV-P24: Enabling Precise and Early HIV Detection

As a result of global efforts to combat the AIDS epidemic, significant progress has been achieved worldwide. According to UNAIDS, while 39 million people still live with HIV globally, the number of new infections has declined by 38% to 1.3 million in 2022 compared to 2010. Despite these improvements, the battle against HIV persists, as only 86% of newly infected individuals are aware of their HIV status, and approximately 630,000 people worldwide have died from AIDS-related illnesses. The significance of prevention, diagnosis, and treatment in the ongoing fight remains paramount.

2023-11-22

Medica 2023: Fapon Accelerates the Development of its Diagnostic Ecosystem

2023-11-10

Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA

2023-11-09

Fapon visits the Economic and Commercial Counselor’s Office of the Embassy of the People’s Republic of China in the Kingdom of Saudi Arabia
Learn More